Sarah London is CEO of Centene Corporation, a Fortune 50 company that focuses on government-sponsored healthcare programs and primarily serves under-insured and uninsured individuals. Centene seeks to improve health and healthcare through sustainable partnerships and a uniquely local approach.

London has spent her career at the intersection of health data, technology and healthcare delivery transformation in an effort to improve health care for people of all backgrounds. Before her 2022 appointment as CEO, she served as Centene’s Vice Chairman, responsible for strategy, technology, ancillary services, enterprise compliance and quality as well as for Centene’s portfolio of independent, non-health plan companies. Prior to Centene, she was an Operating Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. She previously held strategy and commercialization roles at Optum Analytics as well as positions at Accretive Health (now R1 RCM) and Health Leads.

London graduated magna cum laude from Harvard College where she played Division I tennis. She also holds a Master of Business Administration with High Honors from the University of Chicago Booth School of Business.

Women, Female Leadership, Influential Women, CEO, Healthcare, Health, Technology, Data, Women in Tech Investing, Fortune,